Compare CDMOs with EMA GMP certification for EU-market pharmaceutical manufacturing. Filter by product type, member state, and manufacturing capabilities.
349 companies listed
EMA (European Medicines Agency) GMP certification confirms that a manufacturing facility complies with EU Good Manufacturing Practice standards. GMP inspections are conducted by national competent authorities (e.g., BfArM in Germany, ANSM in France, MHRA in the UK) and the resulting GMP certificates are recognized across the EU through mutual recognition.
The EMA maintains Mutual Recognition Agreements with regulatory agencies in the US, Canada, Australia, Japan, Switzerland, and other countries. This means EU GMP inspections may be accepted by these agencies without re-inspection, reducing the regulatory burden on CDMOs serving multiple markets. The Qualified Person (QP) system -- unique to the EU -- provides an additional layer of batch release oversight.
Belgium
Purna Pharmaceuticals NV is an independent Belgian company established in 1986, specializing in contract development and manufacturing of semi-solid (creams, gels, ointments, pastes), liquid, and powder pharmaceutical products. The company has over 30 years of experience and is a preferred contract manufacturing partner for most of the top-10 pharma multinationals. Purna was recently acquired by Ampersand Capital Partners. Manufacturing capabilities include liquids (150L to 10,000L), semi-solids (20L to 2,000L), and powders (10kg to 250kg) with serialization and track-and-trace compliance.
Germany
Rentschler Biopharma is a leading global CDMO focused exclusively on biopharmaceuticals, with over 50 years of industry experience. The company contributed to nearly 25% of FDA-approved biopharmaceuticals in 2023, has supported 180+ biotherapeutics, and serves 180+ clients worldwide. It is an independent family-owned company employing approximately 1,400 people.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.